News and Trends 5 Oct 2020 Galapagos’ Arthritis Drug Approved in EU and Japan Amid US Rejection The recent EU and Japan approvals of the rheumatoid arthritis drug filgotinib contrast with the FDA’s rejection in August. What does this signal for Galapagos, Gilead, and other biotechs working in inflammatory disease? For Galapagos and Gilead, it’s been a rollercoaster few months. In August, the FDA decided against approving their drug filgotinib for treating […] October 5, 2020 - 5 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
In Depth 5 Oct 2020 The Complications Around Patenting Biotechnology Many people around the world start their mornings with a glass of orange juice. What these vitamin C drinkers might not know is that their ability to enjoy this tangy beverage stems from a victory within a complicated field of intellectual property law: biotechnology patents. Back in 1873, microbiologist Louis Pasteur patented a new yeast-making […] October 5, 2020 - 7 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Interview 5 Oct 2020 How is Germany Meeting Patient Demand for Medical Cannabis? Since Germany legalized cannabis for medical use in 2017, we have frequently spoken to Peter Homberg, Partner and Head of the German Life Sciences Practice and the European Cannabis Group at Dentons, a global law firm. Over the years, Peter has provided us with regular updates on the European and German medical cannabis industry. In […] October 5, 2020 - 7 minutesmins - By Larissa Warneck-Silvestrin Share WhatsApp Twitter Linkedin Email
News and Trends 2 Oct 2020 Huge €62M Series B Boost for Mosa Meat’s Cell-Based Burgers The Netherlands-based food technology company Mosa Meat has raised €62M in a Series B round that will be used to bring its cultured beef products a step closer to the market. The funding round was led by the Luxembourg firm Blue Horizon Ventures in collaboration with the Bell Food Group, M Ventures, and others. Of […] October 2, 2020 - 3 minutesmins - By Laura Cowen Share WhatsApp Twitter Linkedin Email
News and Trends 1 Oct 2020 Medicxi to Shake up the Biotech VC Investment Model with €200M Fund UK-based investment firm Medicxi aims to attract more investors to the life sciences with a new fund that lets them cash in on their investments earlier than conventional funds. Last week, Medicxi closed a €200M fund called Medicxi Secondary 1 (MS1), which was co-led by the UK’s Pantheon and Switzerland’s LGT Capital Partners. The aim […] October 1, 2020 - 4 minutesmins - By Victor Kotsev Share WhatsApp Twitter Linkedin Email
Interview 28 Sep 2020 From Big Pharma to Startup CEO: Lessons from Kymriah Developer Gaurav Shah Novartis’ Kymriah, one of the first CAR T-cell therapies to be approved to treat blood cancer, has revolutionized both oncology and gene therapy. Gaurav Shah, now CEO of Rocket Pharmaceuticals, led the team that developed it. Shah began his career as a clinician, but soon moved over into the biotech sector to work at ImClone, […] September 28, 2020 - 9 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 25 Sep 2020 Roche Confirms Pharma Appetite for Inflammatory Disease Treatments Roche’s acquisition of the Irish biotech Inflazome is a vote of confidence for emerging inflammatory disease drugs. How could other companies in the field benefit from this takeover? The inflammation process is essential for our survival, as it helps the body to clear up damage after injury. However, uncontrolled inflammation can also harm us, causing […] September 25, 2020 - 4 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
Expert Advice 23 Sep 2020 How to Invest Smart in Biotech Stocks Anyone investing in public biotech companies will find it challenging to answer the key question: does this company have a good chance to create real value? Medical breakthroughs can result in huge revenues, but being the first to develop and commercialize technologies based on cutting-edge research inherently comes with a high risk of failure. In […] September 23, 2020 - 12 minutesmins - By Carlos de Rojas Share WhatsApp Twitter Linkedin Email
News and Trends 17 Sep 2020 3D Bioprinting Gains a Foothold in Biomedicine 3D printing has revolutionized manufacturing by reducing costs and giving designers and engineers immense flexibility. Could 3D bioprinting do the same for biotechnology? The 3D bioprinting field is still quite young, but it is developing rapidly. In fact, the 3D bioprinting market is expected to grow from €700M ($820M) in 2019 to a massive €4B […] September 17, 2020 - 5 minutesmins - By Kostas Vavitsas Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Sep 2020 The Top 10 Biotech Companies Brewing at Oxford Here are the top biotech companies in Oxford, a city in the U.K. with an old scientific tradition and an enormous output of biotech applications. Oxford is well known for its university, one of the oldest in Europe and considered to be one of the best in the world. Recently, the University of Oxford has […] September 17, 2020 - 8 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2020 T-Cell Therapy Firm Wins Massive €93M Series A to Treat Solid Tumors The Dutch startup Neogene Therapeutics has become the second T-cell therapy developer to raise a spectacularly large Series A round in Europe this year. The Series A round was co-led by the VC firms EcoR1 Capital, Syncona, and Jeito Capital. Neogene Therapeutics will use part of the €93M proceeds to advance its T-cell therapy immuno-oncology […] September 14, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 14 Sep 2020 The Funding Flow Between European and US Life Sciences Funding is the lifeline of innovative ventures. In an increasingly uncertain environment, looking at the records of past investments can be essential for making sense of the future and getting closer to discovering what’s next for the life sciences industry. Exploring the differences between the two major groups of life sciences investors and the funding […] September 14, 2020 - 11 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email